Driehaus Capital Management’s Nurix Therapeutics NRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-715,940
Closed -$8.51M 475
2025
Q1
$8.51M Sell
715,940
-563,751
-44% -$6.7M 0.08% 263
2024
Q4
$24.1M Sell
1,279,691
-5,941
-0.5% -$112K 0.2% 154
2024
Q3
$28.9M Buy
1,285,632
+2,524
+0.2% +$56.7K 0.25% 129
2024
Q2
$26.8M Buy
+1,283,108
New +$26.8M 0.26% 113